Sybx stock forecast.

Forecst.com predicts future values using technical analysis of a large number of analytical parameters. SYBX stock returns are also predicted based on historical data. According to our research, SYBX stock is a good long-term investment. SYBX share price has been in a bull cycle for the past year. Synlogic, Inc. stock trend is positive .The average Solid Power stock price prediction forecasts a potential upside of 136.38% from the current SLDP share price of $1.41. What is SLDP's forecast return on ...Forecast . Price target. 58.00 0.00 0.00%. The 3 analysts offering 1 year price forecasts for SYBX have a max estimate of — and a min estimate of —. Analyst rating. Based on 3 analysts giving stock ratings to SYBX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreFintel reports that on June 6, 2023, Chardan Capital maintained coverage of Synlogic (NASDAQ:SYBX) with a Buy recommendation. Analyst Price Forecast Suggests 1,070.68% Upside As of June 2, 2023 ...

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Golden Grail Technology share forecasts, stock quote and buy / sell signals below. According to present data Golden Grail Technology's GOGY shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Full Company Report for SYBX. View Synlogic, Inc SYBX investment & stock information. Get the latest Synlogic, Inc SYBX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Find real-time BZUN - Baozun Inc stock quotes, company profile, news and forecasts from CNN Business.

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...Synlogic Inc Stock Price Forecast, "SYBX" Predictons for2026. Markets; Forecast . Crypto Forecasts; Top 5 Crypto forecasts; Tether Usdt forecast; Bitcoin forecast; Ethereum forecast; ... Stock, Forex Predictions, Forecasts & Charts – WalletInvestor.com Forecast GET PREMIUM . Crypto Forecast Stock Forecast Forex Forecast ...Sep 28, 2023 · Following the reverse split, shares are trading at about $3.95 this morning. SYBX stock is down 5.6% as of Thursday morning, with some 2,000 shares changing hands. For the record, the company’s ... BNGO Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for BioNano Genomics in the last 3 months. The average price target is $6.33 with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 336.55% change from the last price of $1.45.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Panbela Therapeutics Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 16.00. The ...

BBAI recently reported in-line sales and EBITDA for Q4. However, its full-year revenue outlook came in below Street’s estimates. The company expects its 2023 revenues to be in the range of $155 ...

Average target price for SYBX - Synlogic Inc is predicted at $3.354 within next 1 yearSYBX: Synlogic Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. Analyst Forecast. According to 2 analysts, the average rating for SYBX stock is "Strong Buy." The 12-month stock price forecast is $82.5, which is an increase of 3,351.88% from the latest price.Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 8% and 3.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Find real-time BZUN - Baozun Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Artelo Biosciences Inc have a median target of 5.00, with a high estimate of 40.00 and a low estimate of 5.00. The median ...

Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration. CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious …View the latest Synlogic Inc. (SYBX) stock price, news, historical charts, analyst ratings and financial information from WSJ. The average Biora Therapeutics stock price prediction forecasts a potential upside of 3,932.26% from the current BIOR share price of $1.24. What is BIOR's forecast return on equity (ROE) for 2023-2026? (NASDAQ: BIOR) forecast ROE is …About the Synlogic, Inc. stock forecast. As of 2023 November 21, Tuesday current price of SYBX stock is 2.080$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). Synlogic Announces Reverse Stock Split. CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non ...

SLDP Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Solid Power in the last 3 months. The average price target is $3.00 with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 95.44% change from the last price of $1.54.

May 4, 2023 at 10:00 AM · 5 min read. Wall Street expects a year-over-year decline in earnings on lower revenues when Synlogic, Inc. (SYBX) reports results for the quarter ended March 2023. While ...SYBX: Synlogic - Price and Consensus Chart. Get the latest Price and Consensus Chart for Synlogic from Zacks Investment ResearchThe average Precigen stock price prediction forecasts a potential upside of 792.86% from the current PGEN share price of $1.12. What is PGEN's forecast return on equity (ROE) for 2023-2026? (NASDAQ: PGEN) forecast ROE is N/A, which is considered weak.Nasdaq Futures 15874.25 -23.25 (-0.15%) Dow Jones Futures 34987.00 -32.00 (-0.09%) S&P 500 Futures 4523.75 0.50 (0.01%) EUR/USD 1.09 0.01 (0.57%) …Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 19.23% and 80.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Cineverse Corp have a median target of 7.75, with a high estimate of 9.00 and a low estimate of 6.50. The median estimate ... Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...The average Bionano Genomics stock price prediction forecasts a potential upside of 532.91% from the current BNGO share price of $1.58. What is BNGO's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.13%.

NASDAQ Health Care/Life Sciences Compare to Open 2.10 Prior Close 2.09 (11/22/23) 1 Day SYBX -4.31% DJIA 0.33% Russell 2K 0.67% Health Care/Life Sciences 0.19% Overview Per-Share Earnings,...

EOSE Stock 12 Months Forecast. $10.50. (845.95% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Eos Energy Enterprises in the last 3 months. The average price target is $10.50 with a high forecast of $17.00 and a low forecast of $2.00. The average price target represents a 845.95% change from the last price of $1.11.

Synlogic Announces Reverse Stock Split. CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non ...Find real-time CNVS - Cineverse Corp stock quotes, company profile, news and forecasts from CNN Business.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.What is BigBear.ai's stock price target for 2024? 3 brokerages have issued 1 year price objectives for BigBear.ai's shares. Their BBAI share price targets range from $2.00 to $4.00. On average, they anticipate the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 65.7% from the stock's current price.Our algorithm forecasts the stock price of Synlogic Inc with the highest accuracy in the market. Intratio forecasts every day all US-listed stock prices. Create …The average Payoneer Global stock price prediction forecasts a potential upside of 43.65% from the current PAYO share price of $5.40. What is PAYO's forecast return on equity (ROE) for 2023-2025? (NASDAQ: PAYO) forecast ROE is N/A, which is considered weak.Synlogic Stock Forecast, SYBX stock price prediction. Price target in 14 days: 0.598 USD. The best long-term & short-term Synlogic share price prognosis for 2023 ...Price vs Fair Value. View History. SYBX is trading within a range we consider fairly valued. Price. $1.97. Nov 17, 2023. Fair Value. $1.52. Nov 17, 2023.SYBX Stock Predictions, Articles, and Synlogic Inc News From InvestorPlace From the Web 3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year By Alex Sirois, InvestorPlace ...Nov 28, 2023 · Website. n/a. 72. Aoife Brennan. https://www.synlogictx.com. Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic and immunological diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate ...

SLDP Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Solid Power in the last 3 months. The average price target is $3.00 with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 95.44% change from the last price of $1.54.Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Synlogic, Inc. (SYBX) : Free Stock Analysis Report. Amicus Therapeutics, Inc. (FOLD) : Free Stock ...The average Onconova Therapeutics stock price prediction forecasts a potential upside of 1,589.71% from the current ONTX share price of $0.65. What is ONTX's forecast return on assets (ROA) for 2023-2024?Forecasts powered by: sentiment analysis, fundamental analysis, financials, web traffic data, economic data, analyst opinions, hedge fund trading analysis, competitor analysis, search data, corporate insider activity, online ad spend, and more. Premium members can access custom forecast alerts, see longer forecasts, and access trade suggestions.Instagram:https://instagram. how to take rmds to avoid any taxesamerican funds vs vanguard3 month t billsell my xbox 360 View live Synlogic, Inc. chart to track its stock's price action. Find market predictions, SYBX financials and market news.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get... tela earningsvfiax price Here's what's moving the shares of MX, SYBX, and HOFT. Magnachip Stock Climbs NYSE On Forecast Boost. MX stock is at the top of the New York Stock Exchange today, after the company lifted its ... alpine bank colorado Sep 6, 2023 · Given this risk, we thought we'd take a look at whether Synlogic (NASDAQ:SYBX) shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the annual rate at ... The average Onconova Therapeutics stock price prediction forecasts a potential upside of 1,589.71% from the current ONTX share price of $0.65. What is ONTX's forecast return on assets (ROA) for 2023-2024?Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration. CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, announced ...